Ledger.Open graph →
SEC Form D · filed March 23, 2022

Brooklyn ImmunoTherapeutics, Inc

Offering
$12.0M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BROOKLYN, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Sandra S. Gurrola · Brooklyn, NYExecErin S. Enright · Brooklyn, NYDirectorRoger S. Sidhu · New York, NYExecCharles S. Cherington · New York, NYDirectorHoward J. Federoff · Brooklyn, NYExec · DirectorKevin S. D'Amour · Brooklyn, NYExecErich J. Mohr · Brooklyn, NYDirectorJay S. Sial · New York, NYExecDennis S. Langer · Brooklyn, NYDirectorHeather B. Redman · Seattle, WADirectorSandra S. Gurrola · Brooklyn, NYExecErin S. Enright · Brooklyn, NYDirectorKevin S. D'Amour · Brooklyn, NYExecRoger S. Sidhu · New York, NYExecErich J. Mohr · Brooklyn, NYDirectorCharles S. Cherington · New York, NYDirectorHoward J. Federoff · Brooklyn, NYExec · DirectorJay S. Sial · New York, NYExecDennis S. Langer · Brooklyn, NYDirectorHeather B. Redman · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗